The past week was characterized by further portfolio adjustments within the UMBRELLA Strategy. The focus on artificial intelligence, advanced technologies, and AI infrastructure was further strengthened.
Positions in Palantir Technologies and SpaceX were increased once again. With Dell Technologies, a new company was also added to the strategy. At the same time, the weighting of selected healthcare stocks was reduced.
Bayer was completely sold out of the UMBRELLA Strategy following persistent price weakness. Positions in Revolution Medicines and Johnson & Johnson were also partially reduced.
Following these adjustments, the strategy comprises nine positions with an equity ratio of approximately 97.4% and a cash component of 2.6%.
Overview of portfolio changes
Increased
Sold
Technology and AI weighting continues to rise
The rotation toward artificial intelligence and advanced technologies continued throughout the week.
Palantir Technologies became the largest position in the UMBRELLA Strategy with a weighting of 18.8%, closely followed by SpaceX at 18.2%.
Both positions were further increased. This enhanced the focus on AI, data-driven software, and advanced technologies.
Together with Micron Technology, Intel, Alphabet, and the newly added Dell Technologies, these companies now represent the vast majority of the portfolio. This underscores the strategy’s increasing concentration on technology-related themes.
Palantir becomes largest position
Palantir Technologies continued to gain weight during the week and became the largest individual position in the UMBRELLA Strategy.
Following further purchases, the weighting reached 18.8%. Palantir thus remains a central component of the portfolio’s AI orientation.
SpaceX position further increased
The position in SpaceX was also further expanded during the week.
Through additional purchases, the weighting rose to 18.2%. SpaceX thus continues to be among the largest positions in the UMBRELLA Strategy and remains an important part of the focus on advanced technologies.
Together, Palantir and SpaceX account for approximately 37% of the portfolio. This illustrates their growing importance within the current strategy.
Dell Technologies new to the UMBRELLA Strategy
Dell Technologies has been newly added to the UMBRELLA Strategy.
The company provides access to the fields of servers, data center infrastructure, and enterprise IT, which are increasingly shaped by investments in artificial intelligence.
Following its inclusion, the weighting of Dell Technologies is 3.2%.
Dell Technologies – Stock Profile Summary
Semiconductors remain an important component
Micron Technology and Intel remain significant positions within the UMBRELLA Strategy.
Micron Technology accounts for 11.5% of the portfolio, while Intel is weighted at 10.2%.
Together, both companies reach a share of approximately 21.7%, thereby continuing to ensure a significant orientation toward the semiconductor sector.
Healthcare sector further reduced
The healthcare sector remains an important part of the UMBRELLA Strategy, but its weighting was further reduced during the week.
Revolution Medicines was partially reduced following positive price development. With a weighting of 15.3%, the company nevertheless remains the third-largest position and the largest healthcare asset in the portfolio.
Also Johnson & Johnson was reduced. This freed up capital for the continued rotation into technology stocks. The position currently makes up 6.4% of the portfolio.
Eli Lilly remains part of the strategy with a weighting of 9.5%.
These companies continue to ensure targeted engagement in the healthcare sector alongside the growing technology weighting.
Bayer leaves the UMBRELLA Strategy
Bayer was sold completely from the UMBRELLA Strategy during the week.
The position was closed following persistent price weakness.
The exit intensifies the portfolio’s concentration on artificial intelligence, semiconductors, advanced technologies, and selected healthcare companies.
Current positioning of the UMBRELLA Strategy
Current Positioning
UMBRELLA Strategy · October 12, 2026
Source: wikifolio.com, UMBRELLA · As of: October 12, 2026
Outlook: AI and advanced technologies remain in focus
The UMBRELLA Strategy enters the new week with a stronger concentration on artificial intelligence, semiconductors, and advanced technologies. At the same time, a targeted commitment to the healthcare sector remains in place.
With Palantir and SpaceX as the two largest positions, developments in AI software, infrastructure, and advanced technologies continue to gain importance for the portfolio.
The addition of Dell Technologies expands the focus on AI infrastructure, while Micron Technology and Intel continue to ensure a significant semiconductor weighting.
At the same time, Revolution Medicines, Eli Lilly, and Johnson & Johnson remain important representatives of the healthcare sector.
Company-specific developments, fundamental dynamics, and technical market signals remain critical factors for future portfolio adjustments.
UMBRELLA Strategy: Weekly Video Update
In addition to our weekly review, the current video update offers further insights into developments surrounding the UMBRELLA Strategy and the current market environment.
The video complements the portfolio analysis and provides additional perspectives on the strategy’s current positioning.
